Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.

Weinberg A, Tierney C, Kendall MA, Bosch RJ, Patterson-Bartlett J, Erice A, Hirsch MS, Polsky B; AIDS Clinical Trials Group 360 Team.

J Infect Dis. 2006 Feb 15;193(4):488-93. Epub 2006 Jan 3.

PMID:
16425127
2.

Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity.

Springer KL, Weinberg A.

J Antimicrob Chemother. 2004 Sep;54(3):582-6. Epub 2004 Jul 28. Review.

PMID:
15282241
3.

Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.

Stone SF, Price P, French MA.

J Antimicrob Chemother. 2006 Apr;57(4):585-8. Epub 2006 Feb 27. Review.

PMID:
16504998
4.

Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Kedhar SR, Jabs DA.

Herpes. 2007 Dec;14(3):66-71. Review.

PMID:
18371289
5.

Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).

Steininger C, Puchhammer-Stöckl E, Popow-Kraupp T.

J Clin Virol. 2006 Sep;37(1):1-9. Epub 2006 May 3. Review.

PMID:
16675299
6.

Cytomegalovirus (CMV)-specific cellular immune responses.

Harari A, Zimmerli SC, Pantaleo G.

Hum Immunol. 2004 May;65(5):500-6. Review.

PMID:
15172450
7.

CMV as a cofactor enhancing progression of AIDS.

Griffiths PD.

J Clin Virol. 2006 Apr;35(4):489-92. Epub 2006 Jan 18. Review.

PMID:
16413825
8.

Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.

Lacey SF, Diamond DJ, Zaia JA.

Biol Blood Marrow Transplant. 2004 Jul;10(7):433-47. Review.

9.

Changing trends in cytomegalovirus disease in HIV-infected patients.

Deayton JR.

Herpes. 2001 Jul;8(2):37-40. Review.

PMID:
11867016
10.

Immune restoration disease: a consequence of dysregulated immune responses after HAART.

Stone SF, Price P, French MA.

Curr HIV Res. 2004 Jul;2(3):235-42. Review.

PMID:
15279587
11.

Cytomegalovirus, aging, and HIV: a perfect storm.

Barrett L, Fowke KR, Grant MD.

AIDS Rev. 2012 Jul-Sep;14(3):159-67. Review.

PMID:
22833059
12.

Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Freeman ML, Lederman MM, Gianella S.

Curr HIV/AIDS Rep. 2016 Feb;13(1):10-9. doi: 10.1007/s11904-016-0297-9. Review.

13.

Viruses causing diarrhoea in AIDS.

Pollok RC.

Novartis Found Symp. 2001;238:276-83; discussion 283-8. Review.

PMID:
11444032
14.

Genetically modified immunocompetent cells in HIV infection.

Palù G, Li Pira G, Gennari F, Fenoglio D, Parolin C, Manca F.

Gene Ther. 2001 Nov;8(21):1593-600. Review.

15.

Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.

Torre D, Speranza F, Martegani R.

HIV Med. 2005 Mar;6(2):66-78. Review.

16.

Is cytomegalovirus viraemia a useful tool in managing CMV disease?

Deayton JR.

Sex Transm Infect. 2000 Oct;76(5):342-4. Review. No abstract available.

17.

HIV type 1-specific helper T cells: a critical host defense.

Rosenberg ES, Walker BD.

AIDS Res Hum Retroviruses. 1998 Jun;14 Suppl 2:S143-7. Review. No abstract available.

PMID:
9672231
18.

Role of CMV in immune senescence.

Pawelec G, Derhovanessian E.

Virus Res. 2011 May;157(2):175-9. doi: 10.1016/j.virusres.2010.09.010. Epub 2010 Oct 1. Review.

PMID:
20869407
19.

Perianal cytomegalovirus ulcer in an HIV infected patient: case report and review of literature.

Nico MM, Cymbalista NC, Hurtado YC, Borges LH.

J Dermatol. 2000 Feb;27(2):99-105. Review.

PMID:
10721657
20.

Review of cytomegalovirus coinfection in HIV-infected individuals in Africa.

Grønborg HL, Jespersen S, Hønge BL, Jensen-Fangel S, Wejse C.

Rev Med Virol. 2017 Jan;27(1). doi: 10.1002/rmv.1907. Epub 2016 Oct 7. Review.

PMID:
27714898

Supplemental Content

Support Center